These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 8157136)

  • 1. Antimitotic and teratogenic effects of acyclic nucleotide analogues 1-(S)-(3-hydroxy-2-phosphonomethoxyethyl)cytosine (HPMPC) and 9-(2-phosphonomethoxyethyl) adenine (PMEA).
    Bílá V; Otová B; Jelínek R; Sladká M; Mejsnarová B; Holý A; Kren V
    Folia Biol (Praha); 1993; 39(3):150-61. PubMed ID: 8157136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of rat adjuvant arthritis by some acyclic nucleotide analogs.
    Zídek A; Holý A; Franková D; Otová B
    Eur J Pharmacol; 1995 Nov; 286(3):307-10. PubMed ID: 8608793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic diversity and antiviral activities of acyclic nucleoside phosphonates.
    Aduma P; Connelly MC; Srinivas RV; Fridland A
    Mol Pharmacol; 1995 Apr; 47(4):816-22. PubMed ID: 7723743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotoxicity of purine acyclic nucleotide analogs.
    Otová B; Holý A; Votruba I; Sladká M; Bílá V; Mejsnarová B; Lesková V
    Folia Biol (Praha); 1997; 43(6):225-9. PubMed ID: 9595265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytostatic effect of 9-(2-phosphonomethoxyethyl) adenine (PMEA). III. Rat and mouse carcinomas and sarcomas.
    Otová B; Krenová D; Zídek Z; Holý A; Votruba I; Kren V
    Folia Biol (Praha); 1993; 39(6):311-4. PubMed ID: 7926161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and inhibition of nasopharyngeal carcinoma growth by antiviral phosphonated nucleoside analogs.
    Murono S; Raab-Traub N; Pagano JS
    Cancer Res; 2001 Nov; 61(21):7875-7. PubMed ID: 11691806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines.
    Andrei G; Snoeck R; Piette J; Delvenne P; De Clercq E
    Oncol Res; 1998; 10(10):523-31. PubMed ID: 10338155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of the anti-orf virus activity of alkoxyalkyl esters of CDV, cCDV and (S)-HPMPA.
    Dal Pozzo F; Andrei G; Lebeau I; Beadle JR; Hostetler KY; De Clercq E; Snoeck R
    Antiviral Res; 2007 Jul; 75(1):52-7. PubMed ID: 17184854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor potential of acyclic nucleoside phosphonates.
    De Clercq E; Andrei G; Balzarini J; Hatse S; Liekens S; Naesens L; Neyts J; Snoeck R
    Nucleosides Nucleotides; 1999; 18(4-5):759-71. PubMed ID: 10432678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human renal organic anion transporter 1 (hOAT1) and its role in the nephrotoxicity of antiviral nucleotide analogs.
    Cihlar T; Ho ES; Lin DC; Mulato AS
    Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):641-8. PubMed ID: 11563082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical pharmacology of acyclic nucleotide analogues.
    Bronson JJ; Ho HT; De Boeck H; Woods K; Ghazzouli I; Martin JC; Hitchcock MJ
    Ann N Y Acad Sci; 1990; 616():398-407. PubMed ID: 2078030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of phosphonylmethoxyalkyl derivatives studied with a murine model for abortion induced by equine herpesvirus 1.
    Awan AR; Field HJ
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2478-82. PubMed ID: 8285638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytostatic effects and mechanism of action of antiviral acyclic adenine nucleotide analogs in L1210 mouse leukemia cells.
    Veselý J; Merta A; Votruba I; Rosenberg I; Holý A
    Neoplasma; 1990; 37(2):105-10. PubMed ID: 2342627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) inhibits HIV-1 replication in epithelial cells, but not T-lymphocytes.
    Srinivas RV; Connely M; Fridland A
    Antiviral Res; 1997 Jun; 35(1):23-7. PubMed ID: 9224958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of action of acyclic nucleoside phosphonates against herpes virus replication.
    Neyts J; De Clercq E
    Biochem Pharmacol; 1994 Jan; 47(1):39-41. PubMed ID: 8311844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of intravitreal injections of HPMPC and related nucleoside analogues on intraocular pressure in guinea pig eyes.
    Banker AS; De Clercq E; Taskintuna I; Keefe KS; Bergeron-Lynn G; Freeman WR
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1233-42. PubMed ID: 9620084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy of the acquired immune deficiency syndrome (AIDS): acyclic nucleoside phosphonate analogues.
    De Clercq E
    Int J Immunopharmacol; 1991; 13 Suppl 1():91-8. PubMed ID: 1823910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl] cytosine, an intracellular prodrug for (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine with improved therapeutic index in vivo.
    Bischofberger N; Hitchcock MJ; Chen MS; Barkhimer DB; Cundy KC; Kent KM; Lacy SA; Lee WA; Li ZH; Mendel DB
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2387-91. PubMed ID: 7840575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of retinal toxicity of the anticytomegalovirus drug (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine.
    Dolnak DR; Munguia D; Wiley CA; De Clercq E; Bergeron-Lynn GL; Boscher C; Connor JD; Sherwood C; Capparelli E; Armani R
    Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1557-63. PubMed ID: 1559752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New inhibitors of cytomegalovirus replication: in vitro evaluation, mechanism of action, and in vivo activity.
    Neyts J; De Clercq E
    Verh K Acad Geneeskd Belg; 1994; 56(6):561-92. PubMed ID: 7892749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.